The 32 rating InvestorsObserver gives to Flexion Therapeutics Inc (FLXN) stock puts it near the top of the Drug Manufacturers - Specialty & Generic industry. In addition to scoring higher than 73 percent of stocks in the Drug Manufacturers - Specialty & Generic industry, FLXN’s 32 overall rating means the stock scores better than 32 percent of all stocks.
FLXN has an Overall Score of 32. Find out what this means to you and get the rest of the rankings on FLXN!